Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017
Latest news articles
Added 1 month ago Drug news
Successful Phase I trial of BLU 285 for gastrointestinal stromal tumors is basis for initiating Phase III trial in 2018.- BluePrint Medicines
Blueprint Medicines Corporation announced new Phase 1 clinical data and outlined registration plans for BLU 285, a potent and highly...
Added 10 months ago Drug news
German Institute for Quality and Efficiency in Health Care suggests no additional benefit of Halaven (eribulin) in liposarcomas- Eisai
The German Institute for Quality and Efficiency in Health Care (IQWiG) has published a report which suggests that on formal...
Added 1 year ago Drug news
Phase III data shows improvement in overall survival with Halaven (eribulin) vs dacarbazine in liposarcoma- Eisai
Halaven (eribulin), from Eisai, is an active agent against liposarcoma according to tumour subtype analyses of a Phase III trial...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Since its introduction into clinical practice in the UK 26 years ago, positorn emission tomography (PET) followed by positron emission tomography-computed tomography...
Added 7 months ago
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best...
Added 3 years ago
The main goals were to study the safety and tolerability of the alpha-emitter radium-223 (223Ra) in breast and prostate cancer patients with skeletal metastases. In addition, pain palliation was evaluated.
Added 2 months ago
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.
Background: A non-randomised, phase 2 study showed activity and tolerability of eribulin in advanced or metastatic soft-tissue sarcoma. In this...
Added 1 year ago
Lifetime effectiveness of mifamurtide addition to chemotherapy in nonmetastatic and metastatic osteosarcoma: a Markov process model analysis.
The mortality and progression rates in osteosarcoma differ depending on the presence of metastasis. A decision model would be useful...
Added 1 year ago
Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more
Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.